Showing 20 of 183 recruiting trials for “hepatocellular-carcinoma”
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
RecruitingNCT05705219 ↗
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
👨⚕️ Ahmed El Kaffas, PhD, University of California, San Diego📍 3 sites📅 Started Dec 2023View details ↗
Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
👨⚕️ Fei Li, M.D, The First Affiliated Hospital of Nanchang University📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT06117891 ↗
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
Enrolling by InvitationNCT05429190 ↗
Validation of SMS Protocol for HCC Screening in High-risk Patients
Durvalumab and Tremelimumab in Resectable HCC
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
RecruitingNCT06391879 ↗
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
RecruitingNCT05263830 ↗
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
👨⚕️ Manon ALLAIRE, Dr, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06036563 ↗
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
RecruitingNCT06060769 ↗
Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
👨⚕️ Yaqin Zhang, MD, Ph.D, Fifth Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Sep 2023View details ↗
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
RecruitingNCT06076538 ↗
PET/MR for Characterization of Renal Masses (RMs)
👨⚕️ Ivan Pedrosa, MD, PhD, University of Texas Southwestern Medical Center📍 1 site📅 Started Aug 2023View details ↗
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →